De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
Titel:
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
Auteur:
Chen, Xiu-Chun Jiao, De-Chuang Qiao, Jiang-Hua Wang, Cheng-Zheng Sun, Xian-Fu Lu, Zhen-Duo Li, Lian-Fang Zhang, Chong-Jian Yan, Min Wei, Ya Chen, Bo Feng, Yue-Qing Deng, Miao Ma, Ming-De Plichta, Jennifer K He, You-Wen Liu, Zhen-Zhen